GENinCode plc
Company Profile
Company website
Sector
Medical Equipment and Services (Medical Services)
Description
GENinCode plc (AIM: GENI) is engaged in the risk assessment, prediction and prevention of cardiovascular disease (“CVD”). CVD is the leading cause of death worldwide accounting for approximately 18 million deaths annually.
Investor Access
25
Sep
Event information
The Company will release its unaudited interim results for the six months ended 30 June 2024 on Wednesday, 25 September 2024.
Investors can sign up to Investor Meet Company and add to meet GENinCode Plc, by clicking here https://www.investormeetcompany.com/genincode-plc/register-investorVenue
Online
Time
Wednesday 25 September 2024 at 4pm BST
Financial Calendar
| Event | Date |
| Year End | December 31 |
| Half Year End | 30 June |
| Preliminary Results* | March/April |
| Interim Results* | September |
| AGM* | June |
* Months based on previous announcements of this kind
